Key result
SSRIs remain generally safe but unique secondary mechanisms and side effects dictate individualized treatment selection.
Why the study?
Although SSRIs are considered relatively safe, particular SSRIs are associated with unique secondary and side effects requiring careful selection for each patient.
What are the unique secondary and side effects of particular SSRIs in the treatment of depression?
What are the unique secondary and side effects of particular SSRIs in the treatment of depression?
Understanding the unique side effect profiles of different SSRIs is essential for tailoring depression treatment to individual patients.
Answers are grounded in this paper and cite their sources.
May warrant SSRI selection by individual side-effect profile in depression; leaves open need for head-to-head trials.
Serotonin reuptake inhibitors (SSRIs), along with serotonin norepinephrine reuptake inhibitors (SNRIs) and norepinephrine dopamine reuptake inhibitors (NDRIs), are the first-line drugs in the treatment of depression. Pharmacotherapy of psychiatric disorders with SSRIs is widely practised. Although SSRIs are thought to be relatively safe group of drugs, it is worth to remember that particular SSRIs agents are related to unique secondary and side effects. Knowledge about basic differences between each medication in this group is essential to choose suitable treatment for every patient.
No takes yet. Share an insight, caveat, or question.
Krzewicka-Romaniuk et al. (2020) conducted a review in Depression and psychiatric disorders. Selective Serotonin Reuptake Inhibitors (SSRIs) was evaluated. Although SSRIs are generally safe, individual agents possess unique secondary mechanisms and side effect profiles that must be considered to choose suitable treatment for each patient.
Synapse has enriched 10 related papers. Consider them for comparative context: